Panelists discuss how interventional glaucoma strategies, sustained-release drug delivery implants, and the versatile iDose device advance care by enabling earlier treatment, improving adherence, and expanding surgical options for long-term disease control.
EP. 2: Procedural Pharmaceuticals in Glaucoma: Focus on Bimatoprost and Travoprost Implants
September 12th 2025A panelist discusses how procedural pharmaceuticals like Durysta and iDose offer sustained drug delivery solutions tailored to patient needs, providing long-term efficacy and reducing dependence on daily eye drops.
EP. 3: Surgical Considerations for Implanting Travoprost Intracameral Implant (iDose)
September 12th 2025A panelist discusses how the iDose implant is surgically placed into the scleral wall with precision, can be repositioned if needed, and remains stable even after procedures like goniotomy, making it a versatile option in glaucoma care.